An association map on the effect of flavonoids on the signaling pathways in colorectal cancer

International Journal of Medical Sciences

Volumn 13, Issue 5, 2016, Pages 374-385

  Koosha, Sanaz ^a   Alshawsh, Mohammed A ^a   Yeng, Looi Chung ^a   Seyedan, Atefehalsadat ^a   Mohamed, Zahurin ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Anti colorectal cancer; Colon cancer; Flavonoids; Signaling pathways

Indexed keywords

ACACETIN; APIGENIN; BAICALEIN; CATECHIN; CHRYSIN; CYANIDIN; DELPHINIDIN; ERIODICTYOL; FISETIN; FLAVANONE DERIVATIVE; FLAVANONOL; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; HESPERIDIN; KAEMPFEROL; LUTEOLIN; MALVIDIN CHLORIDE; MYRICETIN; NARINGENIN; NOBILETIN; PELARGONIDIN; PEONIDIN; PROANTHOCYANIDIN; QUERCETIN; SILIBININ; TANGERETIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER INHIBITION; CELL DIFFERENTIATION; CELL MIGRATION; COLORECTAL CANCER; DRUG CYTOTOXICITY; DRUG STRUCTURE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; M PHASE CELL CYCLE CHECKPOINT; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; COLORECTAL TUMOR; DRUG EFFECT; METABOLISM;

ANIMALS; COLORECTAL NEOPLASMS; FLAVANONES; FLAVONES; FLAVONOIDS; FLAVONOLS; HUMANS; SIGNAL TRANSDUCTION;

EID: 84964761818     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.14485     Document Type: Review

References (131)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015; 136: E359-E86.
2. Sanjoaquin M, Appleby P, Thorogood M, Mann J, Key T. Nutrition, lifestyle and colorectal cancer incidence: a prospective investigation of 10 998 vegetarians and non-vegetarians in the United Kingdom. British journal of cancer. 2004; 90: 118-21.
3. De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. The lancet oncology. 2012; 13: 607-15.
4. Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: promising anticancer agents. Medicinal research reviews. 2003; 23: 519-34.
5. Taraphdar AK, Roy M, Bhattacharya R. Natural products as inducers of apoptosis: Implication for cancer therapy and prevention. Curr Sci. 2001; 80: 1387-96.
6. Kocic B, Kitic D, Brankovic S. Dietary flavonoid intake and colorectal cancer risk: evidence from human population studies. J BUON. 2013; 18: 34-43
7. Cai Y, Luo Q, Sun M, Corke H. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life sciences. 2004; 74: 2157-84.
8. Lu J, Papp LV, Fang J, Rodriguez-Nieto S, Zhivotovsky B, Holmgren A. Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer research. 2006; 66: 4410-8.
9. Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Babaian RJ, Pillow PC, et al. Phytoestrogen intake and prostate cancer: A case‐control study using a new database. Nutr Cancer. 1999;33(1):20-5.
10. Kim WK, Bang MH, Kim ES, Kang NE, Jung KC, Cho HJ, et al. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. The Journal of nutritional biochemistry. 2005; 16: 155-62.
11. van der Woude H, Gliszczyńska-Świgło A, Struijs K, Smeets A, Alink GM, Rietjens IM. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer letters. 2003; 200: 41-7.
12. Shan B-E, Wang M-X, Li R-Q. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/β-catenin signaling pathway. Cancer investigation. 2009; 27: 604-12.
13. Araújo JR, Gonçalves P, Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutrition Research. 2011; 31: 77-87.
14. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Molecular nutrition & food research. 2008; 52: 507-26.
15. Gee JM, Hara H, Johnson IT. Suppression of intestinal crypt cell proliferation and aberrant crypt foci by dietary quercetin in rats. Nutrition and cancer. 2002; 43: 193-201.
16. Park CH, Chang JY, Hahm ER, Park S, Kim H-K, Yang CH. Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells. Biochemical and biophysical research communications. 2005; 328: 227-34.
17. Häkkinen SH, Kärenlampi SO, Heinonen IM, Mykkänen HM, Törrönen AR. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. Journal of Agricultural and Food Chemistry. 1999; 47: 2274-9.
18. de Vrie JH, Janssen PK, Hollman PC, van Staveren WA, Katan MB. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer letters. 1997; 114: 141-4.
19. Li W, Du B, Wang T, Wang S, Zhang J. Kaempferol induces apoptosis in human HCT116 colon cancer cells via the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement of p53 Upregulated Modulator of Apoptosis. Chemico-Biological Interactions. 2009; 177: 121-7.
20. Cho H, Kwon G, Park J. Kaempferol induces cell cycle arrest and apoptosis in HT-29 human colon cancer cells. FASEB Journal 2005;:A1694-A1695.
21. Lee HS, Cho HJ, Kwon GT, Park JHY. Kaempferol Downregulates Insulin-like Growth Factor-I Receptor and ErbB3 Signaling in HT-29 Human Colon Cancer Cells. Journal of cancer prevention. 2014; 19: 161.
22. Lee HS, Cho HJ, Yu R, Lee KW, Chun HS, Park JHY. Mechanisms underlying apoptosis-inducing effects of Kaempferol in HT-29 human colon cancer cells. International journal of molecular sciences. 2014; 15: 2722-37.
23. Mutoh M, Takahashi M, Fukuda K, Matsushima-Hibiya Y, Mutoh H, Sugimura T, et al. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis. 2000; 21: 959-63.
24. Nirmala P, Ramanathan M. Effect of kaempferol on lipid peroxidation and antioxidant status in 1, 2-dimethyl hydrazine induced colorectal carcinoma in rats. European journal of pharmacology. 2011; 654: 75-9.
25. Lee J-H, Johnson JV, Talcott ST. Identification of ellagic acid conjugates and other polyphenolics in muscadine grapes by HPLC-ESI-MS. Journal of agricultural and food chemistry. 2005; 53: 6003-10.
26. Kim ME, Ha TK, Yoon JH, Lee JS. Myricetin induces cell death of human colon cancer cells via BAX/BCL2-dependent pathway. Anticancer research. 2014; 34: 701-6.
27. Shiomi K, Kuriyama I, Yoshida H, Mizushina Y. Inhibitory effects of myricetin on mammalian DNA polymerase, topoisomerase and human cancer cell proliferation. Food chemistry. 2013; 139: 910-8.
28. Adhami VM, Syed DN, Khan N, Mukhtar H. Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. Biochemical pharmacology. 2012; 84: 1277-81.
29. Lu X, Cho HJ, Lee HS, Chun HS, Kwon DY, Park JH. Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells. The Journal of nutrition. 2005; 135: 2884-90.
30. Suh Y, Afaq F, Johnson JJ, Mukhtar H. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-κB-signaling pathways. Carcinogenesis. 2009; 30: 300-7.
31. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009; 30: 377-86.
32. Lim DY, Park JHY. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2009; 296: G1060-G8.
33. Tomas-Lorente F, Garcia-Viguera C, Ferreres F, Tomas-Barberan FA. Phenolic compounds analysis in the determination of fruit jam genuineness. Journal of Agricultural and Food Chemistry. 1992; 40: 1800-4.
34. Ramos AA, Marques F, Fernandes-Ferreira M, Pereira-Wilson C. Water extracts of tree Hypericum sps. protect DNA from oxidative and alkylating damage and enhance DNA repair in colon cells. Food and Chemical Toxicology. 2013; 51: 80-6.
35. Alonso-Castro AJ, Domínguez F, García-Carrancá A. Rutin exerts antitumor effects on nude mice bearing SW480 tumor. Archives of medical research. 2013; 44: 346-51.
36. Volate SR, Davenport DM, Muga SJ, Wargovich MJ. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis. 2005; 26: 1450-6.
37. Wargovich MJ, Jimenez A, McKee K, Steele VE, Velasco M, Woods J, et al. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis. 2000; 21: 1149-55.
38. Di Majo D, Giammanco M, La Guardia M, Tripoli E, Giammanco S, Finotti E. Flavanones in Citrus fruit: Structure-antioxidant activity relationships. Food Research International. 2005; 38: 1161-6.
39. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, et al. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis. 1997; 18: 957-65.
40. Park H, Kim M-J, Ha E, Chung J-H. Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. Phytomedicine. 2008; 15: 147-51.
41. Frydoonfar H, McGrath D, Spigelman A. The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin. Colorectal Disease. 2003; 5: 149-52.
42. Totta P, Acconcia F, Leone S, Cardillo I, Marino M. Mechanisms of Naringenin‐induced Apoptotic Cascade in Cancer Cells: Involvement of Estrogen Receptor a and ß Signalling. IUBMB life. 2004; 56: 491-9.
43. Vanamala J, Leonardi T, Patil BS, Taddeo SS, Murphy ME, Pike LM, et al. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis. 2006; 27: 1257-65.
44. Leonardi T, Vanamala J, Taddeo SS, Davidson LA, Murphy ME, Patil BS, et al. Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Experimental biology and medicine. 2010; 235: 710-7.
45. Bhatia N, Zhao J, Wolf DM, Agarwal R. Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin. Cancer letters. 1999; 147: 77-84.
46. Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. Journal of Surgical Research. 2007; 143: 58-65.
47. Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, et al. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene. 2003; 22: 8271-82.
48. Singh RP, Gu M, Agarwal R. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Research. 2008; 68: 2043-50.
49. Kauntz H, Bousserouel S, Gossé F, Raul F. Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells. Apoptosis. 2011; 16: 1042-53.
50. Velmurugan B, Gangar SC, Kaur M, Tyagi A, Deep G, Agarwal R. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharmaceutical research. 2010; 27: 2085-97.
51. Lin C-M, Chen Y-H, Ma H-P, Wang B-W, Chiu J-H, Chua S-K, et al. Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK/AP-1/MMP-2 modulation in vitro. Journal of agricultural and food chemistry. 2012; 60: 12451-7.
52. Kauntz H, Bousserouel S, Gosse F, Marescaux J, Raul F. Silibinin, a natural flavonoid, modulates the early expression of chemoprevention biomarkers in a preclinical model of colon carcinogenesis. International journal of oncology. 2012; 41: 849-54.
53. Ravichandran K, Velmurugan B, Gu M, Singh RP, Agarwal R. Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice. Clinical Cancer Research. 2010; 16: 4595-606.
54. Mutoh M, Takahashi M, Fukuda K, Komatsu H, Enya T, Matsushima-Hibiya Y, et al. Suppression by Flavonoids of Cyclooxygenase‐2 Promoter‐dependent Transcriptional Activity in Colon Cancer Cells: Structure‐Activity Relationship. Cancer Science. 2000; 91: 686-91.
55. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of US adults. The Journal of nutrition. 2007; 137: 1244-52.
56. Wang W, VanAlstyne PC, Irons KA, Chen S, Stewart JW, Birt DF. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines. Nutrition and cancer. 2004; 48: 106-14.
57. Hostetler GL, Riedl KM, Schwartz SJ. Effects of food formulation and thermal processing on flavones in celery and chamomile. Food chemistry. 2013; 141: 1406-11.
58. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Molecular carcinogenesis. 2000; 28: 102-10.
59. Lee Y, Sung B, Kang YJ, Kim DH, Jang J-Y, Hwang SY, et al. Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells. International journal of oncology. 2014; 44: 1599-606.
60. Van Dross R, Xue Y, Knudson A, Pelling JC. The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines. The Journal of nutrition. 2003; 133: 3800S-4S.
61. Turktekin M, Konac E, Onen HI, Alp E, Yilmaz A, Menevse S. Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29). Journal of medicinal food. 2011; 14: 1107-17.
62. Murthy KC, Kim J, Vikram A, Patil BS. Differential inhibition of human colon cancer cells by structurally similar flavonoids of citrus. Food Chemistry. 2012; 132: 27-34.
63. Turner ND, Vanamala J, Leonardi T, Patil BS, Murphy ME, Liu YC, et al. Comparison of the chemoprotection conferred by grapefruit and isolated bioactive compounds against colon cancer. 2006.
64. Adewale O, Brimson J, Odunola O, Gbadegesin M, Owumi S, Isidoro C, et al. The Potential for Plant Derivatives against Acrylamide Neurotoxicity. Phytotherapy Research. 2015.
65. Woo KJ, Jeong Y-J, Inoue H, Park J-W, Kwon TK. Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity. FEBS letters. 2005; 579: 705-11.
66. Schumacher M, Hautzinger A, Rossmann A, Holzhauser S, Popovic D, Hertrampf A, et al. Chrysin blocks topotecan-induced apoptosis in Caco-2 cells in spite of inhibition of ABC-transporters. Biochemical pharmacology. 2010; 80: 471-9.
67. Miyamoto S, Kohno H, Suzuki R, Sugie S, Murakami A, Ohigashi H, et al. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats. Oncology reports. 2006; 15: 1169-73.
68. Sequetto PL, Oliveira TT, Soares ÍA, Maldonado IR, Mello VJ, Pizziolo VR, et al. The flavonoid chrysin attenuates colorectal pathological remodeling reducing the number and severity of pre-neoplastic lesions in rats exposed to the carcinogen 1, 2-dimethylhydrazine. Cell and tissue research. 2013; 352: 327-39.
69. Jeong S-M, Kim S-Y, Kim D-R, Jo S-C, Nam K, Ahn D, et al. Effect of heat treatment on the antioxidant activity of extracts from citrus peels. Journal of agricultural and food chemistry. 2004; 52: 3389-93.
70. Morley KL, Ferguson PJ, Koropatnick J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer letters. 2007; 251: 168-78.
71. Wesołowska O, Wisniewski J, Sroda-Pomianek K, Bielawska-Pohl A, Paprocka M, Dus D, et al. Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants. Journal of natural products. 2012; 75: 1896-902.
72. Pan M-H, Chen W-J, Lin-Shiau S-Y, Ho C-T, Lin J-K. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis. 2002; 23: 1677-84.
73. Hertog MG, Hollman PC, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. Journal of agricultural and food chemistry. 1992; 40: 2379-83.
74. Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, Gaben A-M, et al. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. European journal of pharmacology. 2011; 651: 18-25.
75. Lim DY, Cho HJ, Kim J, Nho CW, Lee KW, Park JH. Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells. BMC gastroenterology. 2012; 12: 9.
76. Pandurangan AK. Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev. 2013; 14: 2201-5.
77. Baskar AA, Ignacimuthu S, Michael GP, Al Numair KS. Cancer chemopreventive potential of luteolin-7-O-glucoside isolated from Ophiorrhiza mungos Linn. Nutrition and cancer. 2011; 63: 130-8.
78. Ramos AA, Pereira-Wilson C, Collins AR. Protective effects of ursolic acid and luteolin against oxidative DNA damage include enhancement of DNA repair in Caco-2 cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2010; 692: 6-11.
79. Wang L, Xie K, Huo H, Shang F, Zou W, Xie M. Luteolin Inhibits Proliferation Induced by IGF-1 Pathway Dependent ERɑ in Human Breast Cancer MCFS7 Cells. Asian Pacific Journal of Cancer Prevention. 2012; 13: 1431-7.
80. Pandurangan A, Dharmalingam P, Sadagopan S, Ganapasam S. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis. Human & experimental toxicology. 2014; 33: 1176-85.
81. Pandurangan A, Ananda Sadagopan S, Dharmalingam P. Inhibitory effect of luteolin on azoxymethane-induced colon carcinogenesis: involvement of iNOS and COX-2. Pharmacog Magazine. 2013.
82. Pandurangan AK, Kumar SAS, Dharmalingam P, Ganapasam S. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2. Pharmacognosy magazine. 2014; 10: S306.
83. Pandurangan AK, Ananda Sadagopan SK, Dharmalingam P, Ganapasam S. Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through activation of Nrf2 signaling. Toxicology mechanisms and methods. 2013; 24: 13-20.
84. Ashokkumar P, Sudhandiran G. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomedicine & Pharmacotherapy. 2008; 62: 590-7.
85. Donald G, Hertzer K, Eibl G. Baicalein-an intriguing therapeutic phytochemical in pancreatic cancer. Current drug targets. 2012; 13: 1772
86. Kim DH, Hossain MA, Kang YJ, Jang JY, Lee YJ, Im E, et al. Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice. International journal of oncology. 2013; 43: 1652-8.
87. Kim SD, Lee YJ, Baik JS, Han JY, Lee CG, Heo K, et al. Baicalein inhibits agonist-and tumor cell-induced platelet aggregation while suppressing pulmonary tumor metastasis via cAMP-mediated VASP phosphorylation along with impaired MAPKs and PI3K-Akt activation. Biochemical pharmacology. 2014; 92: 251-65.
88. Kim S-J, Kim H-J, Kim H-R, Lee S-H, Cho S-D, Choi C-S, et al. Antitumor actions of baicalein and wogonin in HT-29 human colorectal cancer cells. Molecular medicine reports. 2012; 6: 1443-9.
89. Kawabata K, Murakami A, Ohigashi H. Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells. Bioscience, biotechnology, and biochemistry. 2005; 69: 307-14.
90. Miyamoto S, Yasui Y, Ohigashi H, Tanaka T, Murakami A. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. Chem Biol Interact. 2010; 183: 276-83.
91. Miyamoto S, Yasui Y, Tanaka T, Ohigashi H, Murakami A. Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice. Carcinogenesis. 2008; 29: 1057-63.
92. Suzuki R, Kohno H, Murakami A, Koshimizu K, Ohigashi H, Yano M, et al. Citrus nobiletin inhibits azoxymethane-induced large bowel carcinogenesis in rats. Biofactors. 2004; 21: 111-4.
93. Aron PM, Kennedy JA. Flavan‐3‐ols: Nature, occurrence and biological activity. Molecular nutrition & food research. 2008; 52: 79-104.
94. Actis-Goretta L, Ottaviani JI, Keen CL, Fraga CG. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS letters. 2003; 555: 597-600.
95. Nanjo F, Goto K, Seto R, Suzuki M, Sakai M, Hara Y. Scavenging effects of tea catechins and their derivatives on 1, 1-diphenyl-2-picrylhydrazyl radical. Free Radical Biology and Medicine. 1996; 21: 895-902.
96. Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Advances in clinical chemistry. 2011; 53: 155.
97. Fridrich D, Teller N, Esselen M, Pahlke G, Marko D. Comparison of delphinidin, quercetin and (-)‐epigallocatechin‐3‐gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation. Molecular nutrition & food research. 2008; 52: 815-22.
98. Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, et al. The inhibitory effect of (−)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Research. 2007; 67: 6493-501.
99. Shimizu M, Shirakami Y, Sakai H, Tatebe H, Nakagawa T, Hara Y, et al. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Cancer letters. 2008; 262: 10-8
100. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB. (−)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clinical Cancer Research. 2005; 11: 2735-46.
101. Du G-J, Zhang Z, Wen X-D, Yu C, Calway T, Yuan C-S, et al. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients. 2012; 4: 1679-91.
102. Berger SJ, Gupta S, Belfi CA, Gosky DM, Mukhtar H. Green tea constituent (−)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells. Biochemical and biophysical research communications. 2001; 288: 101-5.
103. Chen C, Shen G, Hebbar V, Hu R, Owuor ED, Kong A-NT. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis. 2003; 24: 1369-78.
104. Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochemical and biophysical research communications. 2005; 334: 947-53
105. Adachi S, Nagao T, To S, Joe AK, Shimizu M, Matsushima-Nishiwaki R, et al. (−)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis. 2008; 29: 1986-93
106. Ahmed K, Wei Z-L, Zhao Q-L, Nakajima N, Matsunaga T, Ogasawara M, et al. Role of fatty acid chain length on the induction of apoptosis by newly synthesized catechin derivatives. Chemico-biological interactions. 2010; 185: 182-8.
107. Thakur VS, Amin AR, Paul RK, Gupta K, Hastak K, Agarwal MK, et al. p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG. Cancer letters. 2010; 296: 225-32.
108. Chiou Y-S, Ma NJ-L, Sang S, Ho C-T, Wang Y-J, Pan M-H. Peracetylated (−)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. Journal of agricultural and food chemistry. 2012; 60: 3441-51.
109. Seeram NP, Adams LS, Hardy ML, Heber D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. Journal of agricultural and food chemistry. 2004; 52: 2512-7.
110. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005; 66: 2281-91.
111. Chung W-G, Miranda CL, Stevens JF, Maier CS. Hop proanthocyanidins induce apoptosis, protein carbonylation, and cytoskeleton disorganization in human colorectal adenocarcinoma cells via reactive oxygen species. Food and chemical toxicology. 2009; 47: 827-36.
112. Gorlach S, Wagner W, Podsędek A, Szewczyk K, Koziołkiewicz M, Dastych J. Procyanidins from Japanese quince (Chaenomeles japonica) fruit induce apoptosis in human colon cancer Caco-2 cells in a degree of polymerization-dependent manner. Nutrition and cancer. 2011; 63: 1348-60
113. Lizarraga D, Lozano C, Briedé J, Van Delft J, Touriño S, Centelles J, et al. The importance of polymerization and galloylation for the antiproliferative properties of procyanidin‐rich natural extracts. FEBS journal. 2007; 274: 4802-11.
114. Seeram NP, Adams LS, Zhang Y, Lee R, Sand D, Scheuller HS, et al. Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. Journal of agricultural and food chemistry. 2006; 54: 9329-39.
115. Lizarraga D, Tourino S, Reyes-Zurita FJ, de Kok TM, van Delft JH, Maas LM, et al. Witch Hazel (Hamamelis virginiana) Fractions and the Importance of Gallate Moieties Electron Transfer Capacities in Their Antitumoral Properties. Journal of agricultural and food chemistry. 2008; 56: 11675-82.
116. Engelbrecht A-M, Mattheyse M, Ellis B, Loos B, Thomas M, Smith R, et al. Proanthocyanidin from grape seeds inactivates the PI3-kinase/PKB pathway and induces apoptosis in a colon cancer cell line. Cancer letters. 2007; 258: 144-53.
117. Maldonado ME, Bousserouel S, Gossé F, Lobstein A, Raul F. Implication of NF-κB and p53 in the expression of TRAIL-death receptors and apoptosis by apple procyanidins in human metastatic SW620 cells. Biomedica. 2010; 30: 577-86.
118. Gossé F, Guyot S, Roussi S, Lobstein A, Fischer B, Seiler N, et al. Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcinogenesis. 2005; 26: 1291-5.
119. Nomoto H, Iigo M, Hamada H, Kojima S, Tsuda H. Chemoprevention of colorectal cancer by grape seed proanthocyanidin is accompanied by a decrease in proliferation and increase in apoptosis. Nutrition and cancer. 2004; 49: 81-8.
120. Cvorovic J, Tramer F, Granzotto M, Candussio L, Decorti G, Passamonti S. Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. Arch Biochem Biophys. 2010; 501: 151-7.
121. Jing P, Bomser JA, Schwartz SJ, He J, Magnuson BA, Giusti MM. Structure-function relationships of anthocyanins from various anthocyanin-rich extracts on the inhibition of colon cancer cell growth. J Agric Food Chem. 2008; 56: 9391-8.
122. Zhang Y, Vareed SK, Nair MG. Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables. Life sciences. 2005; 76: 1465-72.
123. Lim S, Xu J, Kim J, Chen TY, Su X, Standard J, et al. Role of anthocyanin‐enriched purple‐fleshed sweet potato p40 in colorectal cancer prevention. Molecular nutrition & food research. 2013; 57: 1908-17
124. Wu X, Prior RL. Systematic identification and characterization of anthocyanins by HPLC-ESI-MS/MS in common foods in the United States: fruits and berries. Journal of agricultural and food chemistry. 2005; 53: 2589-99.
125. Cvorovic J, Tramer F, Granzotto M, Candussio L, Decorti G, Passamonti S. Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. Archives of biochemistry and biophysics. 2010; 501: 151-7.
126. Zu X-y, Zhang Z-Y, Zhang X-W, Yoshioka M, Yang Y-N, Li J. Anthocyanins extracted from Chinese blueberry (Vaccinium uliginosum L.) and its anticancer effects on DLD-1 and COLO205 cells. Chinese medical journal. 2010; 123: 2714-9.
127. Jing P, Qian B, Zhao S, Qi X, Ye L, Giusti MM, et al. Effect of glycosylation patterns of Chinese eggplant anthocyanins and other derivatives on antioxidant effectiveness in human colon cell lines. Food chemistry. 2015; 172: 183-9.
128. Quintos L, Lee I, Kim HJ, Lim J-S, Park J, Sung M-K, et al. Significance of p27kip1 as potential biomarker for intracellular oxidative status. Nutrition research and practice. 2010; 4: 351-5.
129. Yun JM, Afaq F, Khan N, Mukhtar H. Delphinidin, an anthocyanidin in pigmented fruits and vegetables, induces apoptosis and cell cycle arrest in human colon cancer HCT116 cells. Molecular carcinogenesis. 2009; 48: 260-70
130. Huang W-Y, Liu Y-M, Wang J, Wang X-N, Li C-Y. Anti-inflammatory effect of the blueberry anthocyanins malvidin-3-glucoside and malvidin-3-galactoside in endothelial cells. Molecules. 2014; 19: 12827-41.
131. Katsube N, Iwashita K, Tsushida T, Yamaki K, Kobori M. Induction of apoptosis in cancer cells by bilberry (Vaccinium myrtillus) and the anthocyanins. Journal of agricultural and food chemistry. 2003; 51: 68-75.